The latest from Velocity Clinical Research

Mike Zaranek Joins Velocity as CFO

July 16, 2024

Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, today announces it has appointed Mike Zaranek as Chief Financial Officer (CFO). Reporting to Velocity President and CEO Paul Evans with immediate effect, Zaranek will direct the company’s financial goals and accounting, and advise … Read more

VISION Engage Reaches $1 Million in Patient Study Stipends Paid

July 15, 2024

Velocity has now paid more than $1.1 million in patient study stipends through our VISION Engage app. Here’s why this matters: Patients get: Prompt, secure in-app payments Direct bank transfers or virtual debit card options Enhanced visibility and flexibility Sites get: Seamless integration with … Read more

July 9, 2024

Raghu Punnamraju, Chief Technology Officer at Velocity, was recently interviewed by CIO News about applying a lean-value approach to our technical product management, engineering, and architectural strategies. Through the development of our VISION platform, and new frameworks that leverage LLMs, this article details how … Read more

The Importance of Diversity in Clinical Trials with Dr. Jerome Adams

July 8, 2024

The Velocity team had the honor of hosting former U.S. Surgeon General and Chairman of the Board of TOTAL Diversity Clinical Trial Management, Jerome Adams, MD, MPH. He joined an internal call to discuss the importance of diversity in clinical research, highlighting the need … Read more

Velocity Announces New Site in St. Louis, Missouri

July 2, 2024

Velocity has announced a new site in St. Louis, its first in Missouri. The site will be co-located with West County Rheumatology, one of the largest and most active infusion centers in the Midwest, and a region-leading clinic for patients with rheumatoid arthritis, psoriatic … Read more

Closing the gap: Breaking weight-based stigma in clinical trials

June 27, 2024

The narrative that’s been peddled for the past three decades has seen obesity become mired in controversy, leading many – even healthcare professionals – to view it as a lifestyle choice rather than a disease. Nearly 40% of the global population has a body … Read more

Velocity Continues Rapid Growth with Luminis Health Partnership and Expansion into Oncology

June 18, 2024

Paul Evans, Velocity President and CEO, was featured in a Triangle Business Journal article covering Velocity’s recent partnership announcement with Luminis Health. As Paul notes in the article, hospitals play a crucial role in clinical research due to their patient populations, particularly in specialized fields … Read more

Dr. Kowdley Makes Significant Contributions to Pivotal Research Program for Ipsen’s Iqirvo for Primary Biliary Cholangitis

June 12, 2024

Kris Kowdley, MD, contributed significantly to the clinical research program that led to accelerated FDA approval of Ipsen’s Iqirvo, a first-in-class treatment for primary biliary cholangitis (PBC), a rare liver disease. As a primary investigator for the Phase 3 ELATIVE trial, Dr. Kowdley’s site … Read more

Velocity Partners with Luminis Health, Moves into Oncology in the U.S.

June 12, 2024

Velocity Clinical Research, the leading multi-specialty clinical sites business, and Luminis Health, a nonprofit health system providing care for 1.8 million people, today announce their partnership to conduct clinical research within the health group’s organization, connecting more patients with community-based research programs. The partnership … Read more

VISION Achieves 2,000 Patient Randomizations

June 7, 2024

Just one year ago, VISION technology empowered its first patient to self-screen and self-schedule a visit for a clinical trial at Velocity. In March, we announced that VISION had contributed to 1,000 patient randomizations, and that VISION Engage reached 50,000 app downloads. Today, VISION … Read more

Video: Participant Advisory Committee Meeting Insights

June 4, 2024

We can talk about elevating the patient’s voice in clinical research, or we can listen. So let’s listen! In this clip, you’ll hear from both current and past clinical trial participants. They share their first encounters with clinical research and the reasons they decided … Read more

Jerome Adams, MD, MPH, Provides Internal Presentation About the Importance of Diversity in Clinical Trial Inclusion

May 30, 2024

On May 30, Velocity welcomed former Surgeon General Jerome Adams, MD, MPH, to an internal presentation about the importance and direction of diversity in clinical trial inclusion, followed by a Q&A hosted by Paul Evans, President and CEO. The companywide meeting was the first … Read more

Learn more about Velocity's capabilities

Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.

Join a remarkable team doing remarkable work

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.

Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Quality. Continuity. Velocity.